Off-Label Prescribing of Erythropoiesis-Stimulating Proteins in US Hospitals Anuprita PatkarDavid HoldfordMichael Pyles Labeling and Advertising 30 December 2007 Pages: 431 - 440
Evaluation of Electronic Information Resources for Questions Received by a College of Pharmacy Drug Information Center Lamya S. AlnaimNermeen N. Abuelsoud Drug Information 30 December 2007 Pages: 441 - 448
Tracking the Growth of Drug Therapy Literature Using PubMed Dennis F. ThompsonNancy Toedter Williams Drug Information 30 December 2007 Pages: 449 - 455
Survey of Medical Liaison Practices across the Pharmaceutical Industry Christopher M. MarroneJ. Lynn BassCraig J. Klinger Drug Information 30 December 2007 Pages: 457 - 470
An Investigation of Drug Information Needs of Nigerian Pharmacists Waka A. UdeziAzuka C. OparahKenneth U. Enyi Drug Information 30 December 2007 Pages: 471 - 479
Design and Analysis for Drug Abuse Potential Studies: Issues and Strategies for Implementing a Crossover Design Ling ChenYi Tsong Drug Information 30 December 2007 Pages: 481 - 489
Is There a Price to Pay for Short-Term Savings in the Clinical Development of New Pharmaceutical Products? Shelby D. ReedRobert M. CaliffKevin A. Schulman Pharmacoeconomics 30 December 2007 Pages: 491 - 499
The Economics of Personalized Medicine: A Model of Incentives for Value Creation and Capture Louis P. Garrison Jr.M. J. Finley Austin Pharmacoeconomics 30 December 2007 Pages: 501 - 509
Statistical Considerations for Some Studies of Over-the-Counter Drugs Stan C. Lin Biostatistics & Analysis 30 December 2007 Pages: 511 - 516
On the Efficiency of Interim Analyses Applied to Nonclinical Studies SFdS, Groupe Biopharmacie et Santé, Good Preclinical Statistical Practices Working PartyL. Maïofiss-DullinV. Onado Biostatistics & Analysis 30 December 2007 Pages: 517 - 526
A Transition Model for Analysis of Repeated Measure Ordinal Response Data to Identify the Effects of Different Treatments M. GanjaliZ. Rezaee Biostatistics & Analysis 30 December 2007 Pages: 527 - 534
Consequences of Delayed Treatment Effects on Analysis of Time-to-Event Endpoints Gil D. Fine Biostatistics & Analysis 30 December 2007 Pages: 535 - 539
Enhanced Interpretation of Instrument Scales Using the Rasch Model John R. ThompsonJoseph C. CappelleriSebastian Wolf Biostatistics & Analysis 30 December 2007 Pages: 541 - 550